Concluded a joint research agreement with aiwell Inc., a Tokyo Tech venture company, Leverage Co., Ltd., a health food and fitness business operator, and the Tokyo Institute of Technology.

aiwell Co., Ltd.
Concluded a joint research agreement with aiwell Co., Ltd., a Tokyo Tech venture, Leverage Co., Ltd., a health food and fitness business operator, and the Tokyo Institute of Technology.
~ Visualize the effectiveness of protein products using protein analysis “ai-PoP” ~

aiwell Co., Ltd. (Head office: Chiyoda-ku, Tokyo; Representative Director: Hiroyuki Mabuchi), a venture certified company from Tokyo Institute of Technology that is promoting the practical application and social implementation of next-generation comprehensive protein analysis technology (AI proteomics), Leverage Co., Ltd. (Headquarters: Shibuya-ku, Tokyo, Representative: Masayuki Tadashi), National University Corporation Tokyo Institute of Technology (Headquarters: Meguro-ku, Tokyo, President: Kazuya Masu, Principal Investigator: Professor Nobuhiro Hayashi, Department of Life Science and Technology, School of Life Science and Technology) We are pleased to announce that we have entered into a joint research agreement and launched a project on the efficacy of protein products.
[Image 1d34921-51-269099f49dc60b1b965f-0.jpg&s3=34921-51-c0b94c53e9f37ca46ba6e1159337ed53-1200x630.jpg

Background of joint research
Founded in January 2018, aiwell started joint research on the next-generation technology “AI proteomics” with Nobuhiro Hayashi Laboratory, School of Life Science and Technology, Tokyo Institute of Technology (hereafter, Tokyo Institute of Technology) in October 2018. In April 2019, the “Tokyo Institute of Technology/aiwell AI Proteomics Collaborative Research Center” was established on the Ookayama Campus of the Tokyo Institute of Technology. In December 2019, it became a certified venture company from the Tokyo Institute of Technology, and is promoting research and development, practical application, and social implementation of “AI proteomics”.
The conclusion of this joint research agreement was realized in July through a third-party allotment of new shares with Leverage as the underwriter. The main research content is to utilize aiwell’s AI proteomics service “ai-PoP” to analyze the effectiveness (efficacy, efficacy, etc.) of Leverage’s protein products, and to utilize them for product development and sales promotion. .
About aiwell
aiwell is a certified venture company from Tokyo Institute of Technology. In 2018, we started joint research with Nobuhiro Hayashi Laboratory, School of Life Science and Technology, Tokyo Institute of Technology to promote the practical application of AI proteomics (comprehensive protein analysis technology). was established on campus. Professor Hayashi, a developer of AI proteomics and a technical adviser of our company, owns 7 patents, and we have obtained 2 original patents (including 1 pending patent) (*1). We provide services for the medical/pharmaceutical industry and multiple national policy research projects (*2).
In the future, by promoting the social implementation of AI
proteomics, it will be possible to support diagnosis, remote medical care, and drug discovery by AI image judgment before subjective symptoms of illness or injury appear and before it becomes serious. We aim to realize a healthy sustainable society through (Proteomics as a Service).
*1
We have applied for the following two patents (including one pending). ・”Information processing system and program” (pending)
Application date: October 10, 2019, Patent PCT/JP2020/034061 ・”No-wash protein gel stain with pyrene as the basic skeleton” Application date: March 5, 2018 Application number: Patent application 2018-039113
*2
As social implementation research, it has been adopted for the following national policy research projects.
・FY2021 JST Strategic International Collaborative Research Program (SICORP) e-ASIA Collaborative Research Program
・Research Results Optimization and Deployment Support Program (A-STEP) ・Comprehensive start-up support project (Ministry of Agriculture, Forestry and Fisheries version SBIR program)
・Clinical Research Promotion Center, Keio University Hospital Interdisciplinary Research Seeds
Company Profile
[Image 2d34921-51-6c93e35e412ae2c8a78a-1.png&s3=34921-51-caea0d1fa5944347f729e126146617a3-138x24.png
Company name: aiwell Co., Ltd.
Representative Representative Director Hiroyuki Mabuchi
Established January 23, 2018
Location: THE BASE Kojimachi, 9-3 Nibancho, Chiyoda-ku, Tokyo Company website
https://www.aiwelljapan.com
inquiry
Please contact the following for inquiries regarding this release. Person in charge: Kobayashi, aiwell Co., Ltd.
TEL: 080-7954-6881
E-mail: kobayashi-shunsuke@aiwelljapan.com
AI proteomics introduction video
https://www.youtube.com/watch?v=uGXMXDuDV38&t=3s

Details about this release:
https://prtimes.jp/main/html/rd/p/000000051.000034921.html


rehow

Leave a Reply

Your email address will not be published.

%d bloggers like this: